BMT CTN Protocol 1203 (PROGRESS I)

A Multi-center Phase II Trial Randomizing Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls.

Below are protocol-related documents, which may be periodically updated.

            Protocol Co-Chair: Javier Bolanos-Meade, MD (410-614-0738)

            Protocol Co-Chair: John Koreth, MD (617-632-2949)

            Protocol Co-Chair: Ran Reshef , MD

            Protocol Officer: Marcelo Pasquini, MD (414-805-0700)

            Protocol Coordinator: Terry Pritchard (301-251-1161)

            Medical Monitor: Shannon Smiley, MD


The BMT CTN is committed to including widespread transplant community participation in these trials. However, affiliate center applications are not currently being accepted for this study.